SARS-CoV-2 Main Protease Inhibitor High-Throughput Screen

被引：0
|
作者：
Delgado, Renee [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2024年 / 300卷 / 03期
关键词：
Mpro (main protease); high-throughput screening; drug discovery; SARS-CoV-2;
D O I：
10.1016/j.jbc.2024.106070
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1217
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [11] A robust high-throughput fluorescence polarization assay for rapid of SARS-CoV-2 inhibitors
    Yan, Haohao
    Liu, Zhicheng
    Yan, Gangan
    Liu, Xiaoli
    Liu, Xiaoping
    Wang, Yanchang
    Chen, Yunyu
    VIROLOGY, 2022, 574 : 18 - 24
  • [12] High-Throughput Screening for the Potential Inhibitors of SARS-CoV-2 with Essential Dynamic Behavior
    Yang, Zhiwei
    Cai, Xinhui
    Ye, Qiushi
    Zhao, Yizhen
    Li, Xuhua
    Zhang, Shengli
    Zhang, Lei
    CURRENT DRUG TARGETS, 2023, 24 (06) : 532 - 545
  • [13] Application of Acoustic Ejection MS System to High-Throughput Screening for SARS-CoV-2 3CL Protease Inhibitors
    Hasegawa, Tsukasa
    Imamura, Riyo M.
    Suzuki, Tateki
    Hashiguchi, Takao
    Nomura, Takao
    Otsuguro, Satoko
    Maenaka, Katsumi
    Sasaki, Michihito
    Orba, Yasuko
    Sawa, Hirofumi
    Sato, Akihiko
    Okabe, Takayoshi
    Nagano, Tetsuo
    Kojima, Hirotatsu
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2022, 70 (03) : 199 - 201
  • [14] A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process
    Noske, G. D.
    Nakamura, A. M.
    Gawriljuk, V. O.
    Fernandes, R. S.
    Lima, G. M. A.
    Rosa, H. V. D.
    Pereira, H. D.
    Zeri, A. C. M.
    Nascimento, A. F. Z.
    Freire, M. C. L. C.
    Fearon, D.
    Douangamath, A.
    von Delft, F.
    Oliva, G.
    Godoy, A. S.
    JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (18)
  • [15] Fragment Based Drug Discovery of SARS-CoV-2 Main Protease
    Song, W.
    Li, S.
    Chan, A. W. E.
    Coker, A.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2021, 77 : C705 - C705
  • [16] Expedited SARS-CoV-2 Main Protease Inhibitor Discovery through Modular 'Direct-to-Biology' Screening
    Wilders, Harry
    Biggs, George
    Rowe, Sam M.
    Cawood, Emma E.
    Riziotis, Ioannis G.
    Rendina, Alan R.
    Grant, Emma K.
    Pettinger, Jonathan
    Fallon, David J.
    Skehel, Mark
    House, David
    Tomkinson, Nicholas C. O.
    Bush, Jacob T.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 64 (06)
  • [17] In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease
    Abdelrady, Yousef A.
    Ashraf, Naeem Mahmood
    Hamid, Arslan
    Thabet, Hayam S.
    Sayed, Asmaa M.
    Salem, Shimaa H.
    Hassanein, Emad H. M.
    Sayed, Ahmed M.
    FUTURE VIROLOGY, 2023, 18 (05) : 295 - 308
  • [18] 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
    Forrestall, Katrina L.
    Burley, Darcy E.
    Cash, Meghan K.
    Pottie, Ian R.
    Darvesh, Sultan
    CHEMICO-BIOLOGICAL INTERACTIONS, 2021, 335
  • [19] Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid
    Gorshkov, Kirill
    Chen, Catherine Z.
    de la Torre, Juan Carlos
    Martinez-Sobrido, Luis
    Moran, Thomas
    Zheng, Wei
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (06) : 1233 - 1241
  • [20] High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples
    Anand, Sai Priya
    Prevost, Jeremie
    Richard, Jonathan
    Perreault, Josee
    Tremblay, Tony
    Drouin, Mathieu
    Fournier, Marie-Josee
    Lewin, Antoine
    Bazin, Renee
    Finzi, Andres
    TRANSFUSION, 2021, 61 (05) : 1377 - 1382
12345